Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy

Table 3 Cox multivariate analyses of EIF5A2 on NPC patients’ survival

	Significant factors	Hazards ratio	95 % CI	P ^a
OS	Age, per year increase	1.042	1.010–1.075	0.011
OS	EIF5A2(+) vs. EIF5A2(−)	2.949	1.046–8.313	0.041
FFS	EIF5A2(+) vs. EIF5A2(−)	3.128	1.122–8.715	0.029
D-FFS	EIF5A2(+) vs. EIF5A2(−)	3.375	1.040–10.954	0.043
LR-FFS	none

OS overall survival, FFS failure free survival, D-FFS distant failure-free survival, LR-FFS localregional failure-free survival
^aThe covariables: age, gender, T and N categories of NPC tumor, and EIF5A2 expression

ISSN: 1471-2407